By Martha Henry Major HIV prevention trials are underway in African countries, including Botswana, Kenya, South Africa, Uganda, and Zambia. These trials involve hundreds of thousands of people and cost hundreds of millions of dollars. But how will we know if they work?
By Martha Henry When “Treatment as Prevention” was named Science magazine’s Breakthrough of the Year in 2011, there was optimism that we were closing in on AIDS. Results published from the HPTN 052 trial that year showed that in discordant couples, giving antiretroviral treatment (ART) to people with HIV not only was good for their own health, but also lowered the levels of HIV in their blood to undetectable levels, making the…
By Belinda O’Donnell From June to August, I was a peer collaborator for the Mandela Washington Fellows, based at Howard University in Washington D.C. There I met the remarkable Dr. Victor Popoola, an HIV clinician and 2016 Fellow.
By Belinda O’Donnell I saw my first drone in action this January. I was walking on the sidewalk and there it was, 50 feet above me, a small black dot in the sky. The sound was somewhere between a couple of bees and a motorbike. Drones are everywhere, it seems, including the conversation about healthcare delivery. UNICEF and the Government of Malawi have teamed up with Silicon Valley start-up Matternet to…
Continue reading “A Field Guide to Drones for Global Health: The Good, the Bad, the Unknown”
In a paper published in the March issue of Current Opinion in HIV & AIDS, HAI researchers Max Essex and Vlad Novitsky provide evidence that HIV-1 RNA load can guide treatment-for-prevention interventions to slow the AIDS epidemic.
96% reduction in HIV transmission Researchers involved in a large multinational study recently announced that men and women with HIV who take antiretroviral drugs have a 96% lower risk of transmitting the virus to their sexual partners. The study results, just published in The New England Journal of Medicine, were hailed by AIDS experts as a game-changer.
